Skip to main content

Published locations for Ibrutinib bodes well for relapsed mantle-cell lymphoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib bodes well for relapsed mantle-cell lymphoma

User login

  • Reset your password
  • /content/ibrutinib-bodes-well-relapsed-mantle-cell-lymphoma
  • /edermatologynews/article/107033/mantle-cell-lymphoma/ibrutinib-bodes-well-relapsed-mantle-cell
  • /hematologynews/article/107033/mantle-cell-lymphoma/ibrutinib-bodes-well-relapsed-mantle-cell
  • /oncologypractice/article/107033/mantle-cell-lymphoma/ibrutinib-bodes-well-relapsed-mantle-cell
  • /hematology-oncology/article/107033/mantle-cell-lymphoma/ibrutinib-bodes-well-relapsed-mantle-cell
  • /dermatology/article/107033/mantle-cell-lymphoma/ibrutinib-bodes-well-relapsed-mantle-cell-lymphoma
  • /b-cell-lymphoma-icymi/article/107033/mantle-cell-lymphoma/ibrutinib-bodes-well-relapsed-mantle-cell